Miller Fisher's Syndrome

 

 Buy Article Permissions and Reprints

Abstract

Miller Fisher's syndrome is a rare variant of Guillain-Barré's syndrome characterized by the acute development of ataxia, ophthalmoparesis, and areflexia. Most patients have a measureable antibody in serum directed against the GQ1b ganglioside. This antibody is also present in the serum of patients with other forms of Guillain-Barré's syndrome who have prominent ataxia or ophthalmoplegia as part of their clinical presentation. Miller Fisher's syndrome generally is self-limited and has an excellent prognosis.

• Reference

• 1 Collier J. Peripheral neuritis. Edinburgh Med J 1932; 39: 601-618
  PubMedGoogle Scholar
• 2 Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956; 255 (2) 57-65
  CrossrefPubMedGoogle Scholar
• 3 Tatsumoto M, Odaka M, Hirata K, Yuki N. Isolated abducens nerve palsy as a regional variant of Guillain-Barré syndrome. J Neurol Sci 2006; 243 (1–2) 35-38
  CrossrefPubMedGoogle Scholar
• 4 Radziwill AJ, Steck AJ, Borruat FX, Bogousslavsky J. Isolated internal ophthalmoplegia associated with IgG anti-GQ1b antibody. Neurology 1998; 50 (1) 307
  PubMedGoogle Scholar
• 5 Yuki N, Koga M, Hirata K. Isolated internal ophthalmoplegia associated with immunoglobulin G anti-GQ1b antibody. Neurology 1998; 51 (5) 1515-1516
  PubMedGoogle Scholar
• 6 Sugita A, Yanagisawa T, Kamo T, Takahashi Y, Yuki N. Internal ophthalmoplegia with anti-GQ1b IgG antibody. J Neurol 2002; 249 (10) 1475-1476
  CrossrefPubMedGoogle Scholar
• 7 Weiss JA, White JC. Correlation of 1a afferent conduction with the ataxia of Fisher syndrome. Muscle Nerve 1986; 9 (4) 327-332
  CrossrefPubMedGoogle Scholar
• 8 Kornberg AJ, Pestronk A, Blume GM, Lopate G, Yue J, Hahn A. Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes. Neurology 1996; 47 (5) 1317-1320
  CrossrefPubMedGoogle Scholar
• 9 Berlit P, Rakicky J. The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol 1992; 12 (1) 57-63
  PubMedGoogle Scholar
• 10 Jamal GA, Ballantyne JP. The localization of the lesion in patients with acute ophthalmoplegia, ataxia and areflexia (Miller Fisher syndrome). A serial multimodal neurophysiological study. Brain 1988; 111 (Pt 1) 95-114
  CrossrefPubMedGoogle Scholar
• 11 Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol 2004; 148 (1–2) 200-205
  CrossrefPubMedGoogle Scholar
• 12 Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 2001; 70 (1) 50-55
  CrossrefPubMedGoogle Scholar
• 13 Giroud M, Mousson C, Chalopin JM, Rifle G, Dumas R. Miller-Fisher syndrome and pontine abnormalities on MRI: a case report. J Neurol 1990; 237 (8) 489-490
  CrossrefPubMedGoogle Scholar
• 14 Tanaka H, Yuki N, Hirata K. Trochlear nerve enhancement on three-dimensional magnetic resonance imaging in Fisher syndrome. Am J Ophthalmol 1998; 126 (2) 322-324
  CrossrefPubMedGoogle Scholar
• 15 Hosoya T, Adachi M, Yamaguchi K, Yamaguchi K, Kato T, Sugai Y. Abducens nerve enhancement demonstrated by multiplanar reconstruction of contrast-enhanced three-dimensional MRI. Neuroradiology 2001; 43 (4) 295-301
  CrossrefPubMedGoogle Scholar
• 16 Garcia-Rivera CA, Rozen TD, Zhou D , et al. Miller Fisher syndrome: MRI findings. Neurology 2001; 57 (10) 1755
  CrossrefPubMedGoogle Scholar
• 17 Hatanaka T, Higashino H, Yasuhara A, Kobayashi Y. Miller Fisher syndrome: etiological significance of serial blink reflexes and MRI study. Electromyogr Clin Neurophysiol 1992; 32 (6) 317-319
  PubMedGoogle Scholar
• 18 Ito M, Kuwabara S, Odaka M , et al. Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol 2008; 255 (5) 674-682
  CrossrefPubMedGoogle Scholar
• 19 Snyder LA, Rismondo V, Miller NR. The Fisher variant of Guillain-Barré syndrome (Fisher syndrome). J Neuroophthalmol 2009; 29 (4) 312-324
  CrossrefPubMedGoogle Scholar
• 20 Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res 1997; 745 (1–2) 32-36
  CrossrefPubMedGoogle Scholar
• 21 Liu JX, Willison HJ, Pedrosa-Domellöf F. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci 2009; 50 (7) 3226-3232
  CrossrefPubMedGoogle Scholar
• 22 Yuki N, Taki T, Inagaki F , et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993; 178 (5) 1771-1775
  CrossrefPubMedGoogle Scholar
• 23 Overell JR, Hsieh ST, Odaka M, Yuki N, Willison HJ. Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders. Cochrane Database Syst Rev 2007; (1) CD004761
  PubMedGoogle Scholar
• 24 Jacobs BC, O'Hanlon GM, Bullens RW, Veitch J, Plomp JJ, Willison HJ. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain 2003; 126 (Pt 10) 2220-2234
  CrossrefPubMedGoogle Scholar
• 25 Mori M, Kuwabara S, Fukutake T, Hattori T. Intravenous immunoglobulin therapy for Miller Fisher syndrome. Neurology 2007; 68 (14) 1144-1146
  CrossrefPubMedGoogle Scholar
• 26 Odaka M, Yuki N, Yamada M , et al. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain 2003; 126 (Pt 10) 2279-2290
  CrossrefPubMedGoogle Scholar
• 27 Hughes RA, Wijdicks EF, Barohn R , et al; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003; 61 (6) 736-740
  CrossrefPubMedGoogle Scholar